Antibiotic Therapy and the Gut Microbiome: Investigating the Effect of Delivery Route on Gut Pathogens

Abstract

The contribution of the gut microbiome to human health has long been established, with normal gut microbiota conferring protection against invasive pathogens. Antibiotics can disrupt the microbial balance of the gut, resulting in disease and the development of antimicrobial resistance. The effect of antibiotic administration route on gut dysbiosis remains under-studied to date, with conflicting evidence on the differential effects of oral and parenteral delivery. We have profiled the rat gut microbiome following treatment with commonly prescribed antibiotics (amoxicillin and levofloxacin), via either oral or intravenous administration. Fecal pellets were collected over a 13-day period and bacterial populations were analyzed by 16S rRNA gene sequencing. Significant dysbiosis was observed in all treatment groups, regardless of administration route. More profound dysbiotic effects were observed following amoxicillin treatment than those with levofloxacin, with population richness and diversity significantly reduced, regardless of delivery route. The effect on specific taxonomic groups was assessed, revealing significant disruption following treatment with both antibiotics. Enrichment of a number of groups containing known gut pathogens was observed, in particular, with amoxicillin, such as the family Enterobacteriaceae. Depletion of other commensal groups was also observed. The degree of dysbiosis was significantly reduced toward the end of the sampling period, as bacterial populations began to return to pretreatment composition. Richness and diversity levels appeared to return to pretreatment levels more quickly in intravenous groups, suggesting convenient parenteral delivery systems may have a role to play in reducing longer term gut dysbiosis in the treatment of infection.

Impact of Antibiotic Therapies on Resistance Genes Dynamic and Composition of the Animal Gut Microbiota

“…Finally, some studies analyzing the effects of antibiotics on GIM have exploited animal models [38] and also bioreactors mimicking the GIM [39]. This approach allows a controlled quantification of antibiotics to which bacteria are exposed but often relies on a simplification of the bacterial community, thus impairing ecological conclusions of antibiotics action on GIM.…”

Combinations of drugs might increase the survival chances of COVID-19 patients: Literature review till date

“…1. Antibiotics are found to be dysregulating gut microbiota independent of the delivery Route i.e: administered either through oral or Intravenous ways [2058]. Antibiotics are known for dysregulating gut microbiota [1728] and gut microbiota is related to TLR-7 expression at mucosal surfaces [1704] and reduction in TLR-7 is associated with higher mortality in COVID-19 patients [618].…”

SARS-COV-2 acts as a test of Air Pollution, Lifestyle Disorders and Immune Tolerance dysregulation in human body

“…10. Antibiotics are reported to dysregulate gut microbiota and TLR-7 expression at mucosal surfaces independent of the delivery Route i.e: either administered through oral or Intravenous ways [2058]. Antibiotics are known for dysregulating gut microbiota [1728] and gut microbiota is related to TLR-7 expression at mucosal surfaces [1704] and reduction in TLR-…”

“…7. Antibiotics administration (independent of the route)/abuse dysregulates gut Microbiota[2058]. 8.…”